Barclays raised the firm’s price target on Intuitive Surgical (ISRG) to $712 from $686 and keeps an Overweight rating on the shares following the Q4 report. The firm says the company’s 2026 guidance is in line with its recent annual initial growth guidance for the past three years.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical Earnings Call: Growth Surges, Margins Pinched
- Intuitive Surgical’s JURA Feasibility Study: Early Imaging Data With Long-Term Upside for Investors
- Intuitive says over 20M patients operated on with use of da Vinci systems
- Morning Movers: Nvidia up after report of potential China move on H200 chips
- Intuitive Surgical price target lowered to $550 from $580 at Evercore ISI